Properties of Medicinal Plants from India Used in Treatment of Tumor: A Focus on Vanda tessellata, Ipomoea aquatica, and Semen armeninace

Abstract

The anti-tumor characteristics of three Indigenous Indian medicinal plants: Vanda tessellata, Ipomoea aquatica, and Semen armeninace. Vanda tessellata, often known as ‘Ranawara,’ contains bioactive chemicals such as phenanthrenes and bibenzyls, which cause apoptosis, inhibit angiogenesis, and prevent metastasis. I. aquatica, also known as ‘Kalmi Saag,’ contains flavonoids, alkaloids, and polyphenols that inhibit tumor development, enhance immunological response, and reduce oxidative stress. S. armeninace, also known as ‘Musk melon seeds,’ includes cucurbitaceous flavonoids and terpenoids that cause apoptosis, stop the cell cycle, and modify critical signaling pathways involved in carcinogenesis. The study emphasizes the medicinal potential of these plants, as well as the necessity for more research and clinical trials to use their anti-tumor characteristics fully. In addition to their existing therapeutic uses, future studies on these medicinal plants might focus on increasing bioavailability, improving dose forms, and investigating synergistic interactions with conventional cancer therapies. Furthermore, studies into the molecular processes behind their anti-tumor activities might lead to the discovery of new therapeutic targets. Incorporating pharmacogenomics and personalized medicine techniques may improve treatment options while assuring efficacy and reducing side effects. Collaboration among traditional medicine practitioners, pharmacologists, and oncologists can help translate these natural therapies into clinically viable medications. Overall, more research into V. tessellata, I. aquatica, and S. armeninace has the potential to advance cancer therapy and improve patient outcomes.